Antibodies to PB1-F2 protein are induced in response to influenza a virus infection

Archives of Virology

Volumn 154, Issue 10, 2009, Pages 1599-1604

  Krejnusová, Ingrid ^a   Gocníková, Hana ^a   Bystrická, Magdaléna ^a   Blaškovičová, Hana ^b   Poláková, Katarína ^c   Yewdell, Jonathan ^d   Bennink, Jack ^d   Russ, Gustáv ^a  

^a INSTITUTE OF VIROLOGY   (Slovakia)

^b Public Health Authority of the Slovak Republic   (Slovakia)

^c CANCER RESEARCH INSTITUTE   (Slovakia)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PB1 F2 PROTEIN, INFLUENZA A VIRUS; PB1-F2 PROTEIN, INFLUENZA A VIRUS; VIRUS ANTIBODY; VIRUS PROTEIN;

ANIMAL; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HEMAGGLUTINATION INHIBITION TEST; HUMAN; IMMUNOLOGY; IMMUNOPRECIPITATION; INFLUENZA; INFLUENZA VIRUS A; MOUSE; ORTHOMYXOVIRUS INFECTION; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, VIRAL; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, VIRAL; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNOPRECIPITATION; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MICE; ORTHOMYXOVIRIDAE INFECTIONS; VIRAL PROTEINS;

INFLUENZA A VIRUS; INFLUENZAVIRUS A; MUS;

EID: 70350366159     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-009-0479-5     Document Type: Article

References (25)

1. Chen W, Calvo PA, Malide D, Gibbs J, Schubert U, Bacik I, Basta S, O'Neill R, Schickli J, Palese P, Henklein P, Bennink JR, Yewdell JW (2001) A novel influenza A virus mitochondrial protein that induces cell death. Nat Med 7:1306-1312.
2. Pančuchárová H, Russ G (2006) PB1-F2 gene in influenza A viruses of different hemagglutinin subtype. Acta Virol 50:269-272.
3. Gocnikova H, Russ G (2007) Influenza a virus PB1-F2 protein. Acta Virol 51:101-108.
4. Gibbs JS, Malide D, Hornung F, Bennink JR, Yewdell JW (2003) The influenza A virus PB1-F2 protein targets the inner mitochondrial membrane via a predicted basic amphipathic helix that disrupts mitochondrial function. J Virol 77:7214-7224.
5. Yamada H, Chounan R, Higashi Y, Kurihara N, Kido H (2004) Mitochondrial targeting sequence of the influenza A virus PB1-F2 protein and its function in mitochondria. FEBS Lett 578:331-336.
6. Zamarin D, Garcia-Sastre A, Xiao X, Wang R, Palese P (2005) Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog 1:40-54.
7. Carr SM, Carnero E, García-Sastre A, Brownlee GG, Fodor E (2006) Characterization of a mitochondrial-targeting signal in the PB2 protein of influenza viruses. Virology 344:492-508.
8. Mazur I, Anhlan D, Mitzner D, Wixler L, Schubert U, Ludwig S (2008) The proapoptotic influenza A virus protein PB1-F2 regulates viral polymerase activity by interaction with the PB1 protein. Cell Microbiol 10:1140-1152.
9. Zamarin D, Ortigoza MB, Palese P (2006) Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J Virol 80:7976-7983.
10. Coleman JR (2007) The PB1-F2 protein of influenza A virus: Increasing pathogenicity by disrupting alveolar macrophages. Virol J 4:9-13.
11. McAuley JL, Hornung F, Boyd K, Smith AM, McKeon R, Bennink J, Yewdell JW, McCullers JA (2007) Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe 2:240-249.
12. Russ G, Vareckova E, Styk B (1974) Steric effects in the reactions of influenza virus neuraminidase with antibodies. Acta Virol 18:299-306.
13. Chakrabarti S, Brechling K, Moss B (1985) Vaccinia virus expression vector: Coexpression of beta-galactosidase provides visual screening of recombinant virus plaques. Mol Cell Biol 5:3403-3409.
14. Henklein P, Bruns K, Nimtz M, Wray V, Tessmer U, Schubert U (2005) Influenza A virus protein PB1-F2: Synthesis and characterization of the biologically active full length protein and related peptides. J Pept Sci 10:481-490.
15. Grant GA (2002) Synthetic peptides for production of antibodies that recognize intact proteins. Curr Protoc Protein Sci. doi: 10.1002/0471140864.ps1803s28.
16. Yuwen H, Cox JH, Yewdell JW, Bennink JR, Moss B (1993) Nuclear localization of a double-stranded RNA binding protein encoded by the Vaccinia E3L gene. Virology 195:732-744.
17. Potter CW, Oxford JS (1979) Determinants of immunity to influenza infection in man. Br Med Bull 35:69-75.
18. Kim WI, Wu WH, Janke B, Yoon KJ (2006) Characterization of the humoral immune response of experimentally infected and vaccinated pigs to swine influenza viral proteins. Arch Virol 151:23-36.
19. Birch-Machin I, Rowan A, Pick J, Mumford J, Binns M (1997) Expression of the nonstructural protein NS1 of equine influenza A virus: Detection of anti-NS1 Ab in post infection equine sera. J Virol Methods 65:255-263.
20. Tumpey TM, Alvarez R, Swayne DE, Suarez DL (2005) Diagnostic approach for differentiating infected from vaccinated poultry on the basis of Abs to NS1, the nonstructural protein of influenza A virus. J Clin Microbiol 43:676-683.
21. Lambrecht B, Steensels M, van Borm S, Meulemans G, van den Berg T (2007) Development of an M2e-specific enzyme-linked immunosorbent assay for differentiating infected from vaccinated animals. Avian Dis 51:221-226.
22. Black RA, Rota PA, Gorodkova N, Klenk HD, Kendal AP (1993) Antibody response to the M2 protein of influenza A virus expressed in insect cells. J Gen Virol 74:143-146.
23. Liu W, Li H, Chen YH (2003) N-terminus of M2 protein could induce antibodies with inhibitory activity against influenza virus replication. FEMS Immunol Med Microbiol 35:141-146.
24. Feng J, Zhang M, Mozdzanowska K, Zharikova D, Hoff H, Wunner W, Couch RB, Gerhard W (2006) Influenza A virus infection engenders a poor Ab response against the ectodomain of matrix protein 2. Virol J 3:102-114.
25. Khurana S, Suguitan AL Jr, Rivera Y, Simmons CP, Lanzavecchia A, Sallusto F, Manischewitz J, King LR, Subbarao K, Golding H (2009) Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal abs reveals potential vaccine and diagnostic targets. PLoS Med 6(4):e1000049.